Featured News
Press Release
Statement on the Death of Former Congresswoman Nita Lowey
Washington, D.C., March 17, 2025 — The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) were saddened to learn of the passing of former Congresswoman Nita Lowey. For more than t...
All News
AIM Blog
Recognizing AIM’s July Advocate of the Month: Matt Katawicz
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
AIM Blog
Taking Action During Alzheimer’s & Brain Awareness Month
More than 6 million Americans are living with Alzheimer’s. Throughout Alzheimer’s & Brain Awareness Month, federal and state policymakers and...
Press Release
Senate HELP Committee Advances Bipartisan Legislation to Renew Nation’s Commitment to Addressing the Alzheimer’s Crisis
NAPA Reauthorization Act and Alzheimer’s Accountability and Investment Act Washington, D.C., June 15, 2023 — Today the Senate Committee on...
Press Release
FDA Advisory Committee Unanimously Confirms Efficacy and Clinical Benefit of Leqembi for Early Alzheimer's Disease
CHICAGO, June 9, 2023 — Today, an Advisory Committee to the Food and Drug Administration (FDA) unanimously endorsed the efficacy...
AIM Blog
Recognizing AIM’s June Advocate of the Month: Mike Razzi
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
Press Release
Alzheimer’s Association Statement on CMS Announcement of Registry for Access to FDA-Approved Alzheimer’s Treatments
The Alzheimer’s Association recognizes that the Centers for Medicare & Medicaid Services (CMS) has announced their conceptual approach to fulfill...